← CVS Health Interview Insights
This is where I spent most of my mental energy.
Start by framing the problem as a causal inference task with multi-treatment options (SMS, Email, Control) and heterogeneous treatment effects. Propose a modeling approach that leverages the randomized holdouts to estimate conditional average treatment effects (CATE), then use those estimates to optimize contact decisions under business constraints.
Pro tip: Emphasize that you would validate the model's uplift predictions using a holdout set and potentially run a small pilot before full deployment, and discuss how you'd handle non-compliance or partial exposure.
Clarify that you want to estimate the Conditional Average Treatment Effect (CATE) for each treatment (SMS vs. Control, Email vs. Control) given covariates. Ensure the data includes treatment assignment, outcomes (vaccination), and features; check for randomization validity and overlap.
Select a method that handles multiple treatments and high-dimensional features, such as causal forests, X-learner, or meta-learners (T-learner, S-learner) adapted for multi-arm settings. Consider using inverse probability weighting (IPW) to adjust for known treatment probabilities.
Use the known propensity scores (treatment probabilities) to weight the data or as features in the model, ensuring unbiased effect estimates. This is crucial if the randomization probabilities vary across individuals.
Assess model performance using metrics like Qini curve, uplift at various percentiles, and calibration. Use cross-validation or a holdout set to avoid overfitting and ensure the model generalizes.
Use the estimated CATEs to rank individuals by expected uplift for each channel, then allocate contacts to maximize total effect subject to budget or capacity constraints. Consider a pilot to validate before full rollout.
AI-generated suggestions, not part of the candidate's original notes. May be inaccurate — verify before relying on them.
Qini curves and AUUC came to mind fast, that part was fine.
Start by defining the business objective and the need for uplift modeling to optimize incremental impact per channel. Then outline the offline evaluation metrics (e.g., Qini, AUUC) and how to incorporate costs by computing incremental profit curves and cost-sensitive metrics. Finally, discuss validation strategies and practical considerations for deployment.
Pro tip: Emphasize that uplift models should be evaluated on their ability to rank individuals by incremental effect, not just overall accuracy, and that cost differences can drastically change the optimal targeting threshold—so always tie metrics back to ROI.
Explain that uplift modeling aims to estimate the incremental effect of a treatment (e.g., SMS vs. Email) on an outcome. Offline evaluation requires a holdout set with treatment and control groups, and the goal is to rank individuals by predicted uplift to maximize incremental profit.
Use ranking-based metrics like Qini coefficient, AUUC (Area Under the Uplift Curve), or the uplift curve itself. These measure how well the model identifies individuals with positive incremental response. Also consider calibration of uplift predictions if needed.
Convert uplift into expected incremental profit by multiplying predicted uplift by the value of the outcome (e.g., conversion value) and subtracting the treatment cost. For SMS at $0.02 and Email at $0.001, compute the net incremental profit per individual and use it to build a profit curve.
Determine the optimal threshold for targeting based on the profit curve: target individuals where expected incremental profit > 0. Compare thresholds across channels to decide which channel to use for each segment, considering cost differences.
Use cross-validation or bootstrapping to assess metric stability. Simulate deployment by applying the model to a holdout set and computing realized incremental profit. Discuss potential biases (e.g., selection bias) and the need for ongoing monitoring.
AI-generated suggestions, not part of the candidate's original notes. May be inaccurate — verify before relying on them.
Argmax over channel-specific uplift minus cost, pretty standard.
Start by framing the problem as a constrained optimization: maximize total expected value (e.g., incremental profit or retention) subject to a 40% contact limit. Then propose a two-stage approach: first rank customers by predicted uplift or value, then assign the top 40% to the most cost-effective channel based on channel-specific response models and constraints.
Pro tip: Emphasize that the ranking should be based on incremental impact (uplift) rather than pure propensity, and that channel assignment should consider both cost and capacity—this shows you understand causal inference and operational realities.
Clarify the business goal (e.g., maximize profit, minimize churn) and the exact constraint: at most 40% of eligible customers can be contacted. Also note any channel-specific constraints (budget, capacity).
Develop models to estimate each customer's expected response or uplift for each channel, along with the expected cost and value. Use historical data and causal methods (e.g., uplift modeling) to avoid selection bias.
For each customer, compute a score that combines predicted uplift and value (e.g., expected incremental profit). Rank customers in descending order of this score.
For the top 40% of customers, assign each to the channel that maximizes expected net value (uplift minus cost) while respecting channel capacities. This can be formulated as an assignment problem and solved with linear programming or greedy heuristics.
Test the strategy via holdout groups or A/B tests, measure actual incremental lift, and refine models and constraints based on results.
AI-generated suggestions, not part of the candidate's original notes. May be inaccurate — verify before relying on them.
I went with a gated rollout framing, start small, compare vaccination rates adjusted for baseline differences, use sequential testing with a pre-specified stopping rule for harm.
Start by clarifying the business objective and defining the target population, then outline a randomized controlled experiment where users are split between model-based targeting and uniform random targeting. Specify primary and secondary success metrics, along with statistical stopping rules that balance early detection with false positive control.
Pro tip: In healthcare, consider ethical and regulatory constraints: ensure the test doesn't disadvantage any group and that metrics align with clinical outcomes, not just engagement. Also, pre-register your analysis plan to avoid p-hacking and build trust with stakeholders.
Clearly state the goal (e.g., increase conversion or engagement) and formulate null and alternative hypotheses for the comparison between model-based and random targeting.
Choose the randomization unit (e.g., user, session), ensure proper sample size and power, and set up control (uniform random) and treatment (model-based) groups. Consider stratification if needed.
Define primary metric (e.g., conversion rate) and secondary metrics (e.g., revenue, engagement, fairness). Include guardrail metrics to monitor unintended consequences.
Pre-specify stopping rules: fixed horizon or sequential testing with alpha spending. Include criteria for early stopping for efficacy, futility, or harm, and adjust for multiple comparisons.
Use appropriate statistical tests (e.g., t-test, Bayesian methods) to compare groups, check for practical significance, and consider subgroup analyses. Communicate findings with confidence intervals and effect sizes.
AI-generated suggestions, not part of the candidate's original notes. May be inaccurate — verify before relying on them.
Start by defining negative uplift as a causal effect where treated individuals have worse outcomes than they would have under control, then describe how to estimate it using experimental data or causal inference methods. Explain how to identify segments with negative uplift and outline a targeting policy that excludes or adjusts for these segments, while considering business and ethical implications.
Pro tip: Emphasize that detecting negative uplift requires a causal framework, not just correlation, and that ignoring it can lead to ethical and financial harm. Mention that in healthcare, such as at CVS Health, this is critical for patient safety and regulatory compliance.
Clearly define negative uplift as a negative causal effect (treatment harms). Use randomized controlled trials (A/B tests) or causal inference methods like uplift modeling to estimate individual treatment effects.
Analyze the estimated treatment effects to find subgroups where the effect is significantly negative. Use techniques like causal forests, meta-learners, or segmented analysis to detect these segments.
Validate findings with holdout data or additional experiments. Investigate why the model causes harm in these segments (e.g., confounding, data drift, or inherent treatment risk).
Modify the targeting policy to exclude harmful segments from treatment or apply alternative interventions. Consider constraints like fairness, business goals, and ethical guidelines.
Continuously monitor the policy's impact, re-evaluate segments, and update the model as new data arrives to prevent future harm.
AI-generated suggestions, not part of the candidate's original notes. May be inaccurate — verify before relying on them.